Immunizations at Wisconsin Pharmacies: Results of a statewide vaccine registry analysis and pharmacist survey. Issue 28 (9th June 2020)

• Record Type: Journal Article
• Authors: Berce, Philip C.; Bernstein, Rebecca S.; MacKinnon, George E.; Sorum, Sarah; Martin, Erica; MacKinnon, Karen J.; Rein, Lisa E.; Schellhase, Kenneth G.
• Is Part Of: Vaccine. Volume 38:Issue 28(2020)
• Page Start: 4448
• Page End: 4456
• Publication Date: 2020-06-09
• Subjects: Community pharmacy services -- Pharmacies -- Immunization -- Pharmacists; Vaccines -- Periodicals; 615.372
• DOI: 10.1016/j.vaccine.2020.04.043
• Languages: English
• ISSNs: 0264-410X

Abstract

Graphical abstract: Highlights: Community pharmacies pose a potential strategy for increasing vaccine uptake. The Wisconsin Immunization Registry allows for quantitative analysis of immunization doses provided at pharmacies. The immunizations with highest proportion given at pharmacies are zoster and influenza. Organizational change is key for maximizing pharmacists as immunizers. Abstract: Background: There is currently limited data in the United States on the proportion of immunization doses given at pharmacies outside the influenza vaccine. This study aims to obtain baseline information on the percentage of vaccine doses administered at pharmacies in Wisconsin and to understand the immunization barriers for Wisconsin pharmacists, to inform interventions to increase immunization access at pharmacies. Methods: Aggregated data from the Wisconsin Immunization Registry (WIR) was obtained for all vaccines administered at pharmacies to patients over the age of six from July 2017 through June 2018. In addition, a survey on attitudes towards and barriers to vaccination was sent to 2000 Wisconsin pharmacists with 236 respondents yielding a 12% response rate. Results: WIR data demonstrates that zoster and influenza vaccines have the highest proportion of doses administered at pharmacies (39% and 20%, respectively). Human papillomavirus (HPV) vaccines have the lowest proportion of doses at 0.2%. Pharmacy survey shows that 86% provide immunizations. Most stock influenza vaccines (84%), whereas much fewer stock HPV vaccines (21%). The greatest immunization barriers for the pharmacy respondents include billing and reimbursement challenges and competing demands for staff. Conclusions: Despite the barriers, community pharmacies have significant potential to address vaccination gaps. Physicians, patients, and legislative bodies are generally well-accepting of pharmacists as immunizers. Pharmacists, in order to be fully utilized as immunizers, must engage in active communication with patients and be willing to collaborate with physicians. Legislative policy and health insurance reimbursement reforms are also necessary to facilitate further pharmacist participation in immunization.